KVD001 Injection
KVD001-201
Phase 2 small_molecule completed
Quick answer
KVD001 Injection for Diabetic Macular Edema is a Phase 2 program (small_molecule) at Kalvista Pharmaceuticals (Ireland) Limited with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Kalvista Pharmaceuticals (Ireland) Limited
- Indication
- Diabetic Macular Edema
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed